Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 23Fatigue 17Neoplasms 9Depression 6Pain 5Colorectal Neoplasms 4Vomiting 3Prostatic Neoplasms 3Ovarian Neoplasms 3Nausea 3Lung Neoplasms 3Glioma 3Esophageal Neoplasms 3Colonic Neoplasms 3Anxiety Disorders 3Sleep Wake Disorders 2Sleep Initiation and Maintenance Disorders 2Rectal Neoplasms 2Polycystic Ovary Syndrome 2Parasomnias 2Oligodendroglioma 2Obesity 2Motor Activity 2Meningioma 2Medulloblastoma 2Lymphedema 2Leukemia 2Head and Neck Neoplasms 2Gliosarcoma 2Glioblastoma 2

Interventions

endostar protein 1coenzyme Q10 1apatinib 1Yoga 1Ubiquinone 1Tamoxifen 1Surveys and Questionnaires 1Referral and Consultation 1Quality of Life 1Palliative Care 1Oxaliplatin 1Melatonin 1Gardening 1Fentanyl 1Exercise 1Educational Status 1Diet Therapy 1Chemoradiotherapy 1Capecitabine 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Quality of Life × Yoga × Clear all
NCT02309112 2015-02-10

Y-ACT

University of Oxford

Phase NA Completed
15 enrolled 14 charts

Quality of Life

Data powered by HemOnc (CC BY 4.0) Colophon âš¡